- Trials with a EudraCT protocol (19)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (3)
19 result(s) found for: Posture.
Displaying page 1 of 1.
EudraCT Number: 2013-003941-41 | Sponsor Protocol Number: ABR46374 | Start Date*: 2013-11-07 |
Sponsor Name:Medisch Spectrum Twente | ||
Full Title: Reversibility of pulmonary function after inhaling salbutamol in different doses in standard and forward leaning body posture in asthmatic children | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002722-23 | Sponsor Protocol Number: NL44755.044.13 | Start Date*: 2013-07-09 |
Sponsor Name:Medisch Spectrum Twente | ||
Full Title: The protective effect of a single dose inhaled steroid with different body postures against exercise induced bronchoconstriction | ||
Medical condition: Exercise Induced Bronchoconstriction | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004297-34 | Sponsor Protocol Number: 236252 | Start Date*: 2018-03-31 | |||||||||||
Sponsor Name:Aston University | |||||||||||||
Full Title: A placebo controlled double blind randomised controlled proof of concept study of zolpidem for the treatment of motor and cognitive deficits in late-stage Parkinson’s | |||||||||||||
Medical condition: Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003903-35 | Sponsor Protocol Number: : NUTH-2005-03384 | Start Date*: 2006-01-19 |
Sponsor Name:Newcastle-upon-Tyne Hospitals NHS Trust | ||
Full Title: : The Role of Keppra in the Treatment of Tremor in Multiple Sclerosis | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005049-21 | Sponsor Protocol Number: MRZ-R-201212_01001_N_2 | Start Date*: 2017-01-12 |
Sponsor Name:LLC Merz Pharma, Russia | ||
Full Title: Multi-center Open Comparative Randomized Trial of Clinical and Neurophysiological Efficacy and Safety of Xeomin (Botulinum Toxin Type A) vs. Botox (Complex of Botulinum Toxin Type A and Hemaggluti... | ||
Medical condition: • Cerebral Palsy • Spastic Paraplegia and Hemiparesis • Equine and Equinovarus Foot Deformation | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2004-002086-20 | Sponsor Protocol Number: A-94-52120-098 | Start Date*: 2005-03-09 |
Sponsor Name:Ipsen Pharma GmbH | ||
Full Title: Open, multicentre study on the equivalent efficacy and safety of Botulinum toxin A (500 Units Dysport®) in the treatment of heterogeneous forms of cervical dystonia | ||
Medical condition: Cervical dystonia (CD), one of the most common forms of focal dystonia, is characterised by an altered head posture, pain in the the neck and shoulder region and hypertrophy of the concerned muscle... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001235-27 | Sponsor Protocol Number: AVXS-101-CL-101 | Start Date*: 2020-04-06 |
Sponsor Name:AveXis, Inc. | ||
Full Title: Phase I Gene Transfer Clinical Trial for Spinal Muscular Atrophy Type 1 Delivering AVXS-101 | ||
Medical condition: Gene Replacement Therapy Clinical Trial for Patients with Spinal Muscular Atrophy Type 1 | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2007-005414-40 | Sponsor Protocol Number: LEV-SM-2006 | Start Date*: 2007-12-21 | |||||||||||
Sponsor Name:AZIENDA SANITARIA N. 3 GENOVESE | |||||||||||||
Full Title: Efficacy and activity of levetiracetam on Multiple Sclerosis cerebellar symptoms: a multicenters double blind, randomized, placebo-controlled, cross over study | |||||||||||||
Medical condition: Patients with an established and stable Multiple Sclerosis (according to Poser criteria). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003089-14 | Sponsor Protocol Number: CCTU0218 | Start Date*: 2019-12-03 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | |||||||||||||
Full Title: Azathioprine Immunosuppression and Disease Modification in Parkinson’s Disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial | |||||||||||||
Medical condition: Parkinson's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006438-33 | Sponsor Protocol Number: CCB-CRC-07-02 | Start Date*: 2008-06-12 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: Influence of I(f) blockade on orthostatic tolerance and sympathic activity in healthy subjects. | ||
Medical condition: Orthostatic intolerance means the defective adaptation of the cardiovascular system to the upright position. One of the major Form of this disorder, the postural orthostatic tachycardia syndrome (o... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-005118-36 | Sponsor Protocol Number: NOH401 | Start Date*: 2014-06-30 | |||||||||||
Sponsor Name:Chelsea Therapeutics, Incorporated | |||||||||||||
Full Title: A clinical study of Patients with symptomatic neurogenic orthostatic HypOtENsion to assess sustaIned effects of droXidopa therapy | |||||||||||||
Medical condition: Symptomatic neurogenic orthostatic hypotension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000686-16 | Sponsor Protocol Number: CHDR1953 | Start Date*: 2020-03-26 | |||||||||||
Sponsor Name:Centre for Human Drug Research | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled crossover study to validate finger tapping tasks for the quantification of levodopa/carbidopa effects in Parkinson’s Disease patients. | |||||||||||||
Medical condition: Parkinson's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004497-28 | Sponsor Protocol Number: 0028022 | Start Date*: 2011-12-13 | |||||||||||
Sponsor Name:Orion Pharma | |||||||||||||
Full Title: A RANDOMISED, MULTICENTRE, TWO-ARM, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE EFFICACY AND SAFETY CLINICAL STUDY OF IBUPROFEN 5% ROLL-ON GEL IN ADULT HUMAN PATIENTS WITH PAIN RE... | |||||||||||||
Medical condition: Pain related to uncomplicaated ankle injuries. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) LT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004496-37 | Sponsor Protocol Number: 0028021 | Start Date*: 2011-11-25 | |||||||||||
Sponsor Name:Orion Pharma | |||||||||||||
Full Title: A RANDOMISED, MULTICENTRE, TWO-ARM, PARALLEL GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE EFFICACY AND SAFETY CLINICAL STUDY OF IBUPROFEN 5% GEL IN ADULT HUMAN PATIENTS WITH PAIN RELATED TO... | |||||||||||||
Medical condition: Pain related to uncomplicated ankle injuries | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) LT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004886-15 | Sponsor Protocol Number: MTA:CT4-09-18--Sponsor:18I-Fsg08 | Start Date*: 2019-05-17 | |||||||||||
Sponsor Name:IBSA INSTITUT BIOCHIMIQUE SA | |||||||||||||
Full Title: Evaluation of Treatment Satisfaction, Effectiveness and Tolerability in Subjects treated with Low-dose Diclofenac Epolamine Soft Capsules for Acute, Mild or Moderate Musculoskeletal Pain | |||||||||||||
Medical condition: Patients with acute, mild or moderate musculoskeletal pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003360-19 | Sponsor Protocol Number: P070123 | Start Date*: 2008-11-17 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Etude de l'effet de la pioglitazone dans l'ataxie de Friedreich : étude "preuve de concept" | |||||||||||||
Medical condition: Ataxie de Friedreich | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002467-27 | Sponsor Protocol Number: 2007 Neuro 12 | Start Date*: 2008-01-24 | |||||||||||||||||||||
Sponsor Name:Salford Royal NHS Foundation Trust | |||||||||||||||||||||||
Full Title: Antidyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients with Parkinson's Disease and Levodopa-Induced Dyskinesias | |||||||||||||||||||||||
Medical condition: Patients with idiopathic Parkinson's disease and levodopa-induced dyskinesias | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-000764-30 | Sponsor Protocol Number: HOT-LOCO | Start Date*: 2021-07-06 | |||||||||||||||||||||
Sponsor Name:Karolinska University Hospital | |||||||||||||||||||||||
Full Title: Hyperbaric Oxygen for Treatment of Long COVID syndrome; A Randomized, Placebo-Controlled, Double-Blind, Phase II Clinical Trial | |||||||||||||||||||||||
Medical condition: Long COVID, post-acute COVID-19 Syndrome, post COVID-19 Syndrome (ICD-10 U09.0) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: SE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001427-79 | Sponsor Protocol Number: TIRCON2012V1-EXT | Start Date*: 2015-03-27 |
Sponsor Name:ApoPharma Inc. | ||
Full Title: Long-term Safety and Efficacy Study of Deferiprone in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) | ||
Medical condition: Pantothenate kinase-associated neurodegeneration (PKAN) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) GB (Completed) IT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
